NCT02721732 2026-01-29Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are MetastaticM.D. Anderson Cancer CenterPhase 2 Active not recruiting157 enrolled 26 charts
NCT02837042 2022-06-21Trial of Pembrolizumab for Advanced Penile Squamous Cell CarcinomaUniversity of Alabama at BirminghamPhase 2 Terminated6 enrolled 10 charts